NDC 71205-836 Phenazopyridine Hydrochloride

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Get all the details for National Drug Code (NDC) 71205-836 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
71205-836
Proprietary Name:
Phenazopyridine Hydrochloride
Product Type: [3]
Labeler Name: [5]
Labeler Code:
71205
Marketing Category: [8]
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date: [9]
05-08-2023
End Marketing Date: [10]
04-30-2025
Listing Expiration Date: [11]
04-30-2025
Exclude Flag: [12]
D
Code Navigator:

Product Characteristics

Color(s):
BROWN (C48332 - MAROON)
Shape:
ROUND (C48348)
Size(s):
7 MM
10 MM
Imprint(s):
G15
G17
Score:
1

Code Structure Chart

Product Details

What is NDC 71205-836?

The NDC code 71205-836 is assigned by the FDA to the product Phenazopyridine Hydrochloride which is product labeled by Proficient Rx Lp. The product's dosage form is . The product is distributed in 9 packages with assigned NDC codes 71205-836-00 100 tablet in 1 bottle , 71205-836-06 6 tablet in 1 bottle , 71205-836-10 10 tablet in 1 bottle , 71205-836-12 12 tablet in 1 bottle , 71205-836-20 20 tablet in 1 bottle , 71205-836-24 24 tablet in 1 bottle , 71205-836-55 500 tablet in 1 bottle , 71205-836-90 90 tablet in 1 bottle , 71205-836-96 96 tablet in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Phenazopyridine Hydrochloride?

Phenazopyridine HCL is indicated for the symptomatic relief of pain, burning, urgency frequency, and other discomforts arising from irritation of the mucosa of the lower urinary tract caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.The use of Phenazopyridine for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. The drug should be used for symptomatic relief of pain and not as a substitute for specific surgery or antimicrobial therapy.Phenazopyridine is compatible with antimicrobial therapy and can help relieve pain and discomfort during the interval before antimicrobial therapy controls the infection.Treatment of a urinary tract infection with Phenazopyridine should not exceed 2 days. There is no evidence that the combined administration of Phenazopyridine and an antimicrobial provides greater benefit than administration of the antimicrobial alone after 2 days. (See Dosage and Administration.)

Which are Phenazopyridine Hydrochloride UNII Codes?

The UNII codes for the active ingredients in this product are:

  • PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17)
  • PHENAZOPYRIDINE (UNII: K2J09EMJ52) (Active Moiety)

Which are Phenazopyridine Hydrochloride Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".